Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
2009 1
2010 1
2014 2
2016 3
2017 5
2018 4
2019 4
2020 7
2021 8
2022 8
2023 5
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis.
Spindle TR, Zamarripa CA, Russo E, Pollak L, Bigelow G, Ward AM, Tompson B, Sempio C, Shokati T, Klawitter J, Christians U, Vandrey R. Spindle TR, et al. Among authors: sempio c. Drug Alcohol Depend. 2024 Apr 1;257:111267. doi: 10.1016/j.drugalcdep.2024.111267. Epub 2024 Mar 13. Drug Alcohol Depend. 2024. PMID: 38498958 Clinical Trial.
β-Caryophyllene Inhibits Monoacylglycerol Lipase Activity and Increases 2-Arachidonoyl Glycerol Levels In Vivo: A New Mechanism of Endocannabinoid-Mediated Analgesia?
Klawitter J, Weissenborn W, Gvon I, Walz M, Klawitter J, Jackson M, Sempio C, Joksimovic SL, Shokati T, Just I, Christians U, Todorovic SM. Klawitter J, et al. Among authors: sempio c. Mol Pharmacol. 2024 Jan 10;105(2):75-83. doi: 10.1124/molpharm.123.000668. Mol Pharmacol. 2024. PMID: 38195158 Free PMC article.
Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms.
Domen CH, Sillau S, Liu Y, Adkins M, Rajkovic S, Bainbridge J, Sempio C, Klawitter J, Leehey MA. Domen CH, et al. Among authors: sempio c. Mov Disord. 2023 Jul;38(7):1341-1346. doi: 10.1002/mds.29447. Epub 2023 May 22. Mov Disord. 2023. PMID: 37212386 Clinical Trial.
Associations between Prenatal and Postnatal Exposure to Cannabis with Cognition and Behavior at Age 5 Years: The Healthy Start Study.
Moore BF, Salmons KA, Hoyt AT, Swenson KS, Bates EA, Sauder KA, Shapiro ALB, Wilkening G, Kinney GL, Neophytou AM, Sempio C, Klawitter J, Christians U, Dabelea D. Moore BF, et al. Among authors: sempio c. Int J Environ Res Public Health. 2023 Mar 10;20(6):4880. doi: 10.3390/ijerph20064880. Int J Environ Res Public Health. 2023. PMID: 36981794 Free PMC article.
46 results